Biomarkers for prediction of cardiovascular events [2]

JAMA

Volumn 302, Issue 19, 2009, Pages 2089-2090

  Rosenstein, Robert S ^a   Parra, David ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEOMICS; RISK BENEFIT ANALYSIS; RISK FACTOR; BLOOD; NOTE; RISK;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; RISK;

EID: 71749114034     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1637     Document Type: Letter

References (4)

1. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA. 2009;302(1):49-57.
2. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631-2639. (Pubitemid 44969122)
3. Koenig W. Cardiovascular biomarkers: added value with an integrated approach? Circulation. 2007;116(1):3-5. (Pubitemid 47016239)
4. Ardigo D, Assimes TL, Fortmann SP, et al; ADVANCE Investigators. Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics. 2007;31(3):402-409. (Pubitemid 350127780)